Premium
O5‐06‐05: EXPLORING ACE‐2 AS A NOVEL THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE
Author(s) -
Evans Charles E.,
Miners Scott,
Good Mark A.,
Kehoe Patrick G.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - Norwegian
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.3029
Subject(s) - pathogenesis , hippocampal formation , angiotensin converting enzyme 2 , renin–angiotensin system , medicine , endocrinology , pharmacology , receptor , angiotensin 1 , angiotensin ii , activator (genetics) , chemistry , disease , blood pressure , covid-19 , infectious disease (medical specialty)
Paris, France; CEA Life Sciences Division, Institute for Biomedical Imaging, Medical Imaging Research Center, Fontenay-aux-Roses, France; Division of Cellular Neurobiology, Zoological Institute, Technische Universit€at Braunschweig, Brunswick, Germany; Helmholtz Centre for Infection Research, AG Neuroinflammation und Neurodegeneration, Brunswick, Germany; INSERM, Universit e Paris-Sud, Universit e Paris-Saclay, Orsay, France; Centre National de la Recherche Scientifique, Universit e Paris-Sud, Universit e Paris-Saclay, Orsay, France; Sorbonne Universit es, University Pierre and Marie Curie, Paris, France; Laboratory of Mass Spectrometry, INSERM, Centre National de la Recherche Scientifique,, Sorbonne Universit es, Pierre et Marie Curie, Paris, France; Division of Cellular Neurobiology, Zoological Institute, Technische Universit€at Braunschweig, Brunswick, Germany; CEA Life Sciences Division, Institute for Biomedical Engineering, Medical Imaging Research Center, Fontenay-aux-Roses, France. Contact e-mail: nathalie.cartier@ inserm.fr